Skip to main content
Top
Published in: Molecular Neurodegeneration 1/2014

Open Access 01-12-2014 | Research article

Associations between brain microstructures, metabolites, and cognitive deficits during chronic HIV-1 infection of humanized mice

Authors: Michael D Boska, Prasanta K Dash, Jaclyn Knibbe, Adrian A Epstein, Sidra P Akhter, Natasha Fields, Robin High, Edward Makarov, Stephen Bonasera, Harris A Gelbard, Larisa Y Poluektova, Howard E Gendelman, Santhi Gorantla

Published in: Molecular Neurodegeneration | Issue 1/2014

Login to get access

Abstract

Background

Host-species specificity of the human immunodeficiency virus (HIV) limits pathobiologic, diagnostic and therapeutic research investigations to humans and non-human primates. The emergence of humanized mice as a model for viral infection of the nervous system has overcome such restrictions enabling research for HIV-associated end organ disease including behavioral, cognitive and neuropathologic deficits reflective of neuroAIDS. Chronic HIV-1 infection of NOD/scid-IL-2Rgc null mice transplanted with human CD34+ hematopoietic stem cells (CD34-NSG) leads to persistent viremia, profound CD4+ T lymphocyte loss and infection of human monocyte-macrophages in the meninges and perivascular spaces. Murine cells are not infected with virus.

Methods

Changes in mouse behavior were measured, starting at 8 weeks after viral infection. These were recorded coordinate with magnetic resonance spectroscopy metabolites including N-acetylaspartate (NAA), creatine and choline. Diffusion tensor magnetic resonance imaging (DTI) was recorded against multispectral immunohistochemical staining for neuronal markers that included microtubule associated protein-2 (MAP2), neurofilament (NF) and synaptophysin (SYN); for astrocyte glial fibrillary acidic protein (GFAP); and for microglial ionized calcium binding adaptor molecule 1 (Iba-1). Oligodendrocyte numbers and integrity were measured for myelin associated glycoprotein (MAG) and myelin oligodendrocyte glycoprotein (MOG) antigens.

Results

Behavioral abnormalities were readily observed in HIV-1 infected mice. Longitudinal open field activity tests demonstrated lack of habituation indicating potential for memory loss and persistent anxiety in HIV-1 infected mice compared to uninfected controls. End-point NAA and creatine in the cerebral cortex increased with decreased MAG. NAA and glutamate decreased with decreased SYN and MAG. Robust inflammation reflected GFAP and Iba-1 staining intensities. DTI metrics were coordinate with deregulation of NF, Iba-1, MOG and MAG levels in the whisker barrel and MAP2, NF, MAG, MOG and SYN in the corpus callosum.

Conclusions

The findings are consistent with some of the clinical, biochemical and pathobiologic features of human HIV-1 nervous system infections. This model will prove useful towards investigating the mechanisms of HIV-1 induced neuropathology and in developing novel biomarkers and therapeutic strategies for disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kraft-Terry SD, Stothert AR, Buch S, Gendelman HE: HIV-1 neuroimmunity in the era of antiretroviral therapy. Neurobiol Dis. 2010, 37: 542-548. 10.1016/j.nbd.2009.12.015.PubMedCentralCrossRefPubMed Kraft-Terry SD, Stothert AR, Buch S, Gendelman HE: HIV-1 neuroimmunity in the era of antiretroviral therapy. Neurobiol Dis. 2010, 37: 542-548. 10.1016/j.nbd.2009.12.015.PubMedCentralCrossRefPubMed
2.
go back to reference Robertson K, Liner J, Heaton R: Neuropsychological assessment of HIV-infected populations in international settings. Neuropsychol Rev. 2009, 19: 232-249. 10.1007/s11065-009-9096-z.PubMedCentralCrossRefPubMed Robertson K, Liner J, Heaton R: Neuropsychological assessment of HIV-infected populations in international settings. Neuropsychol Rev. 2009, 19: 232-249. 10.1007/s11065-009-9096-z.PubMedCentralCrossRefPubMed
3.
go back to reference Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, CHARTER Group: HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011, 17: 3-16. 10.1007/s13365-010-0006-1.PubMedCentralCrossRefPubMed Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, CHARTER Group: HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011, 17: 3-16. 10.1007/s13365-010-0006-1.PubMedCentralCrossRefPubMed
4.
go back to reference Pozniak A, Rackstraw S, Deayton J, Barber T, Taylor S, Manji H, Melvin D, Croston M, Nightingale S, Kulasegaram R, Pitkanen M, Winston A: HIV-associated neurocognitive disease: case studies and suggestions for diagnosis and management in different patient sub-groups. Antivir Ther. 2014, 19 (1): 1-13.CrossRefPubMed Pozniak A, Rackstraw S, Deayton J, Barber T, Taylor S, Manji H, Melvin D, Croston M, Nightingale S, Kulasegaram R, Pitkanen M, Winston A: HIV-associated neurocognitive disease: case studies and suggestions for diagnosis and management in different patient sub-groups. Antivir Ther. 2014, 19 (1): 1-13.CrossRefPubMed
5.
go back to reference Gorantla S, Poluektova L, Gendelman HE: Rodent models for HIV-associated neurocognitive disorders. Trends Neurosci. 2012, 35: 197-208. 10.1016/j.tins.2011.12.006.PubMedCentralCrossRefPubMed Gorantla S, Poluektova L, Gendelman HE: Rodent models for HIV-associated neurocognitive disorders. Trends Neurosci. 2012, 35: 197-208. 10.1016/j.tins.2011.12.006.PubMedCentralCrossRefPubMed
6.
go back to reference Jaeger LB, Nath A: Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesis. Dis Model Mech. 2012, 5: 313-322. 10.1242/dmm.008763.PubMedCentralCrossRefPubMed Jaeger LB, Nath A: Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesis. Dis Model Mech. 2012, 5: 313-322. 10.1242/dmm.008763.PubMedCentralCrossRefPubMed
7.
go back to reference Koppensteiner H, Brack-Werner R, Schindler M: Macrophages and their relevance in Human Immunodeficiency Virus Type I infection. Retrovirology. 2012, 9: 82-10.1186/1742-4690-9-82.PubMedCentralCrossRefPubMed Koppensteiner H, Brack-Werner R, Schindler M: Macrophages and their relevance in Human Immunodeficiency Virus Type I infection. Retrovirology. 2012, 9: 82-10.1186/1742-4690-9-82.PubMedCentralCrossRefPubMed
8.
go back to reference Palmer S, Josefsson L, Coffin JM: HIV reservoirs and the possibility of a cure for HIV infection. J Intern Med. 2011, 270: 550-560. 10.1111/j.1365-2796.2011.02457.x.CrossRefPubMed Palmer S, Josefsson L, Coffin JM: HIV reservoirs and the possibility of a cure for HIV infection. J Intern Med. 2011, 270: 550-560. 10.1111/j.1365-2796.2011.02457.x.CrossRefPubMed
9.
go back to reference Gelbard HA, Gendelman HE: Lipids and cognition make good bedfellows for neuroAIDS. Neurology. 2013, 81 (17): 1480-1481. 10.1212/WNL.0b013e3182a958ba.CrossRefPubMed Gelbard HA, Gendelman HE: Lipids and cognition make good bedfellows for neuroAIDS. Neurology. 2013, 81 (17): 1480-1481. 10.1212/WNL.0b013e3182a958ba.CrossRefPubMed
10.
go back to reference Gannon P, Khan MZ, Kolson DL: Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol. 2011, 24: 275-283. 10.1097/WCO.0b013e32834695fb.PubMedCentralCrossRefPubMed Gannon P, Khan MZ, Kolson DL: Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol. 2011, 24: 275-283. 10.1097/WCO.0b013e32834695fb.PubMedCentralCrossRefPubMed
11.
go back to reference del Palacio M, Alvarez S, Munoz-Fernandez MA: HIV-1 infection and neurocognitive impairment in the current era. Rev Med Virol. 2012, 22: 33-45. 10.1002/rmv.711.CrossRefPubMed del Palacio M, Alvarez S, Munoz-Fernandez MA: HIV-1 infection and neurocognitive impairment in the current era. Rev Med Virol. 2012, 22: 33-45. 10.1002/rmv.711.CrossRefPubMed
12.
go back to reference Yilmaz A, Price RW, Gisslen M: Antiretroviral drug treatment of CNS HIV-1 infection. J Antimicrob Chemother. 2012, 67: 299-311. 10.1093/jac/dkr492.CrossRefPubMed Yilmaz A, Price RW, Gisslen M: Antiretroviral drug treatment of CNS HIV-1 infection. J Antimicrob Chemother. 2012, 67: 299-311. 10.1093/jac/dkr492.CrossRefPubMed
13.
go back to reference Kahouadji Y, Dumurgier J, Sellier P, Lapalus P, Delcey V, Bergmann J, Hugon J, Paquet C: Cognitive function after several years of antiretroviral therapy with stable central nervous system penetration score. HIV Med. 2013, 14: 311-315. 10.1111/j.1468-1293.2012.01052.x.CrossRefPubMed Kahouadji Y, Dumurgier J, Sellier P, Lapalus P, Delcey V, Bergmann J, Hugon J, Paquet C: Cognitive function after several years of antiretroviral therapy with stable central nervous system penetration score. HIV Med. 2013, 14: 311-315. 10.1111/j.1468-1293.2012.01052.x.CrossRefPubMed
14.
go back to reference McCombe JA, Vivithanaporn P, Gill MJ, Power C: Predictors of symptomatic HIV-associated neurocognitive disorders in universal health care. HIV Med. 2013, 14: 99-107. 10.1111/j.1468-1293.2012.01043.x.CrossRefPubMed McCombe JA, Vivithanaporn P, Gill MJ, Power C: Predictors of symptomatic HIV-associated neurocognitive disorders in universal health care. HIV Med. 2013, 14: 99-107. 10.1111/j.1468-1293.2012.01043.x.CrossRefPubMed
15.
go back to reference Smurzynski M, Wu K, Letendre S, Robertson K, Bosch RJ, Clifford DB, Evans S, Collier AC, Taylor M, Ellis R: Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort. Aids. 2011, 25: 357-365. 10.1097/QAD.0b013e32834171f8.PubMedCentralCrossRefPubMed Smurzynski M, Wu K, Letendre S, Robertson K, Bosch RJ, Clifford DB, Evans S, Collier AC, Taylor M, Ellis R: Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort. Aids. 2011, 25: 357-365. 10.1097/QAD.0b013e32834171f8.PubMedCentralCrossRefPubMed
16.
go back to reference Airoldi M, Bandera A, Trabattoni D, Tagliabue B, Arosio B, Soria A, Rainone V, Lapadula G, Annoni G, Clerici M, Gori A: Neurocognitive impairment in HIV-infected naive patients with advanced disease: the role of virus and intrathecal immune activation. Clin Dev Immunol. 2012, 2012: 467154-PubMedCentralCrossRefPubMed Airoldi M, Bandera A, Trabattoni D, Tagliabue B, Arosio B, Soria A, Rainone V, Lapadula G, Annoni G, Clerici M, Gori A: Neurocognitive impairment in HIV-infected naive patients with advanced disease: the role of virus and intrathecal immune activation. Clin Dev Immunol. 2012, 2012: 467154-PubMedCentralCrossRefPubMed
18.
go back to reference Clark US, Cohen RA: Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals. Curr Opin Investig Drugs. 2010, 11: 884-900.PubMedCentralPubMed Clark US, Cohen RA: Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals. Curr Opin Investig Drugs. 2010, 11: 884-900.PubMedCentralPubMed
19.
go back to reference Spudich SS, Ances BM: Neurologic complications of HIV infection: highlights from the 2013 conference on retroviruses and opportunistic infections. Topics in antiviral Med. 2013, 21: 100-108. Spudich SS, Ances BM: Neurologic complications of HIV infection: highlights from the 2013 conference on retroviruses and opportunistic infections. Topics in antiviral Med. 2013, 21: 100-108.
20.
go back to reference Gorantla S, Makarov E, Finke-Dwyer J, Gebhart CL, Domm W, Dewhurst S, Gendelman HE, Poluektova LY: CD8+ cell depletion accelerates HIV-1 immunopathology in humanized mice. J Immunol. 2010, 184: 7082-7091. 10.4049/jimmunol.1000438.PubMedCentralCrossRefPubMed Gorantla S, Makarov E, Finke-Dwyer J, Gebhart CL, Domm W, Dewhurst S, Gendelman HE, Poluektova LY: CD8+ cell depletion accelerates HIV-1 immunopathology in humanized mice. J Immunol. 2010, 184: 7082-7091. 10.4049/jimmunol.1000438.PubMedCentralCrossRefPubMed
21.
go back to reference Gorantla S, Makarov E, Finke-Dwyer J, Castanedo A, Holguin A, Gebhart CL, Gendelman HE, Poluektova L: Links between progressive HIV-1 infection of humanized mice and viral neuropathogenesis. Am J Pathol. 2010, 177: 2938-2949. 10.2353/ajpath.2010.100536.PubMedCentralCrossRefPubMed Gorantla S, Makarov E, Finke-Dwyer J, Castanedo A, Holguin A, Gebhart CL, Gendelman HE, Poluektova L: Links between progressive HIV-1 infection of humanized mice and viral neuropathogenesis. Am J Pathol. 2010, 177: 2938-2949. 10.2353/ajpath.2010.100536.PubMedCentralCrossRefPubMed
22.
go back to reference Dash PK, Gorantla S, Gendelman HE, Knibbe J, Casale GP, Makarov E, Epstein AA, Gelbard HA, Boska MD, Poluektova LY: Loss of neuronal integrity during progressive HIV-1 infection of humanized mice. J Neurosci. 2011, 31: 3148-3157. 10.1523/JNEUROSCI.5473-10.2011.PubMedCentralCrossRefPubMed Dash PK, Gorantla S, Gendelman HE, Knibbe J, Casale GP, Makarov E, Epstein AA, Gelbard HA, Boska MD, Poluektova LY: Loss of neuronal integrity during progressive HIV-1 infection of humanized mice. J Neurosci. 2011, 31: 3148-3157. 10.1523/JNEUROSCI.5473-10.2011.PubMedCentralCrossRefPubMed
23.
go back to reference Dash PK, Gendelman HE, Roy U, Balkundi S, Alnouti Y, Mosley RL, Gelbard HA, McMillan J, Gorantla S, Poluektova LY: Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice. Aids. 2012, 26: 2135-2144. 10.1097/QAD.0b013e328357f5ad.PubMedCentralCrossRefPubMed Dash PK, Gendelman HE, Roy U, Balkundi S, Alnouti Y, Mosley RL, Gelbard HA, McMillan J, Gorantla S, Poluektova LY: Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice. Aids. 2012, 26: 2135-2144. 10.1097/QAD.0b013e328357f5ad.PubMedCentralCrossRefPubMed
24.
go back to reference Sun B, Abadjian L, Rempel H, Calosing C, Rothlind J, Pulliam L: Peripheral biomarkers do not correlate with cognitive impairment in highly active antiretroviral therapy-treated subjects with human immunodeficiency virus type 1 infection. J Neurovirol. 2010, 16: 115-124. 10.3109/13550280903559789.CrossRefPubMed Sun B, Abadjian L, Rempel H, Calosing C, Rothlind J, Pulliam L: Peripheral biomarkers do not correlate with cognitive impairment in highly active antiretroviral therapy-treated subjects with human immunodeficiency virus type 1 infection. J Neurovirol. 2010, 16: 115-124. 10.3109/13550280903559789.CrossRefPubMed
25.
go back to reference Norman LR, Basso M, Kumar A, Malow R: Neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research. Curr Drug Abuse Rev. 2009, 2: 143-156. 10.2174/1874473710902020143.CrossRefPubMed Norman LR, Basso M, Kumar A, Malow R: Neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research. Curr Drug Abuse Rev. 2009, 2: 143-156. 10.2174/1874473710902020143.CrossRefPubMed
26.
go back to reference Stanford SC: The open field test: reinventing the wheel. J Psychopharmacol. 2007, 21: 134-135. 10.1177/0269881107073199.CrossRefPubMed Stanford SC: The open field test: reinventing the wheel. J Psychopharmacol. 2007, 21: 134-135. 10.1177/0269881107073199.CrossRefPubMed
27.
go back to reference Bolivar VJ, Caldarone BJ, Reilly AA, Flaherty L: Habituation of activity in an open field: a survey of inbred strains and F1 hybrids. Behav Genet. 2000, 30: 285-293. 10.1023/A:1026545316455.CrossRefPubMed Bolivar VJ, Caldarone BJ, Reilly AA, Flaherty L: Habituation of activity in an open field: a survey of inbred strains and F1 hybrids. Behav Genet. 2000, 30: 285-293. 10.1023/A:1026545316455.CrossRefPubMed
28.
go back to reference Prut L, Belzung C: The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol. 2003, 463: 3-33. 10.1016/S0014-2999(03)01272-X.CrossRefPubMed Prut L, Belzung C: The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol. 2003, 463: 3-33. 10.1016/S0014-2999(03)01272-X.CrossRefPubMed
29.
go back to reference Willi R, Winter C, Wieske F, Kempf A, Yee BK, Schwab ME, Singer P: Loss of EphA4 impairs short-term spatial recognition memory performance and locomotor habituation. Genes Brain Behav. 2012, 11 (8): 1020-1031.PubMed Willi R, Winter C, Wieske F, Kempf A, Yee BK, Schwab ME, Singer P: Loss of EphA4 impairs short-term spatial recognition memory performance and locomotor habituation. Genes Brain Behav. 2012, 11 (8): 1020-1031.PubMed
30.
go back to reference Lamprea MR, Cardenas FP, Setem J, Morato S: Thigmotactic responses in an open-field. Braz J Med Biol Res. 2008, 41: 135-140. 10.1590/S0100-879X2008000200010.CrossRefPubMed Lamprea MR, Cardenas FP, Setem J, Morato S: Thigmotactic responses in an open-field. Braz J Med Biol Res. 2008, 41: 135-140. 10.1590/S0100-879X2008000200010.CrossRefPubMed
32.
go back to reference Weed MR, Steward DJ: Neuropsychopathology in the SIV/macaque model of AIDS. Front Biosci. 2005, 10: 710-727. 10.2741/1566.CrossRefPubMed Weed MR, Steward DJ: Neuropsychopathology in the SIV/macaque model of AIDS. Front Biosci. 2005, 10: 710-727. 10.2741/1566.CrossRefPubMed
33.
go back to reference Gold LH, Fox HS, Henriksen SJ, Buchmeier MJ, Weed MR, Taffe MA, Huitron-Resendiz S, Horn TF, Bloom FE: Longitudinal analysis of behavioral, neurophysiological, viral and immunological effects of SIV infection in rhesus monkeys. J Med Primatol. 1998, 27: 104-112. 10.1111/j.1600-0684.1998.tb00234.x.CrossRefPubMed Gold LH, Fox HS, Henriksen SJ, Buchmeier MJ, Weed MR, Taffe MA, Huitron-Resendiz S, Horn TF, Bloom FE: Longitudinal analysis of behavioral, neurophysiological, viral and immunological effects of SIV infection in rhesus monkeys. J Med Primatol. 1998, 27: 104-112. 10.1111/j.1600-0684.1998.tb00234.x.CrossRefPubMed
34.
go back to reference Gorantla S, Sneller H, Walters L, Sharp JG, Pirruccello SJ, West JT, Wood C, Dewhurst S, Gendelman HE, Poluektova L: Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice. J Virol. 2007, 81: 2700-2712. 10.1128/JVI.02010-06.PubMedCentralCrossRefPubMed Gorantla S, Sneller H, Walters L, Sharp JG, Pirruccello SJ, West JT, Wood C, Dewhurst S, Gendelman HE, Poluektova L: Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice. J Virol. 2007, 81: 2700-2712. 10.1128/JVI.02010-06.PubMedCentralCrossRefPubMed
35.
go back to reference Epstein AA, Narayanasamy P, Dash PK, High R, Bathena SP, Gorantla S, Poluektova LY, Alnouti Y, Gendelman HE, Boska MD: Combinatorial assessments of brain tissue metabolomics and histopathology in rodent models of human immunodeficiency virus infection. J Neuroimmune Pharmacol. 2013, 8 (5): 1224-1238. 10.1007/s11481-013-9461-9.PubMedCentralCrossRefPubMed Epstein AA, Narayanasamy P, Dash PK, High R, Bathena SP, Gorantla S, Poluektova LY, Alnouti Y, Gendelman HE, Boska MD: Combinatorial assessments of brain tissue metabolomics and histopathology in rodent models of human immunodeficiency virus infection. J Neuroimmune Pharmacol. 2013, 8 (5): 1224-1238. 10.1007/s11481-013-9461-9.PubMedCentralCrossRefPubMed
36.
go back to reference Koopmans PP, Ellis R, Best BM, Letendre S: Should antiretroviral therapy for HIV infection be tailored for intracerebral penetration?. Neth J Med. 2009, 67: 206-211.PubMed Koopmans PP, Ellis R, Best BM, Letendre S: Should antiretroviral therapy for HIV infection be tailored for intracerebral penetration?. Neth J Med. 2009, 67: 206-211.PubMed
37.
go back to reference Kranick SM, Nath A: Neurologic complications of HIV-1 infection and its treatment in the era of antiretroviral therapy. Continuum. 2012, 18: 1319-1337.PubMedCentralPubMed Kranick SM, Nath A: Neurologic complications of HIV-1 infection and its treatment in the era of antiretroviral therapy. Continuum. 2012, 18: 1319-1337.PubMedCentralPubMed
38.
go back to reference Price RW, Swanstrom R: Targeting chronic central nervous system HIV infection. Antivir Ther. 2012, 17: 1227-1231. 10.3851/IMP2414.CrossRefPubMed Price RW, Swanstrom R: Targeting chronic central nervous system HIV infection. Antivir Ther. 2012, 17: 1227-1231. 10.3851/IMP2414.CrossRefPubMed
39.
go back to reference Amaral AI, Meisingset TW, Kotter MR, Sonnewald U: Metabolic aspects of neuron-oligodendrocyte-astrocyte interactions. Front Endocrinol. 2013, 4: 54-CrossRef Amaral AI, Meisingset TW, Kotter MR, Sonnewald U: Metabolic aspects of neuron-oligodendrocyte-astrocyte interactions. Front Endocrinol. 2013, 4: 54-CrossRef
40.
go back to reference Madhavarao CN, Chinopoulos C, Chandrasekaran K, Namboodiri MA: Characterization of the N-acetylaspartate biosynthetic enzyme from rat brain. J Neurochem. 2003, 86: 824-835. 10.1046/j.1471-4159.2003.01905.x.CrossRefPubMed Madhavarao CN, Chinopoulos C, Chandrasekaran K, Namboodiri MA: Characterization of the N-acetylaspartate biosynthetic enzyme from rat brain. J Neurochem. 2003, 86: 824-835. 10.1046/j.1471-4159.2003.01905.x.CrossRefPubMed
41.
go back to reference Chakraborty G, Mekala P, Yahya D, Wu G, Ledeen RW: Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J Neurochem. 2001, 78: 736-745. 10.1046/j.1471-4159.2001.00456.x.CrossRefPubMed Chakraborty G, Mekala P, Yahya D, Wu G, Ledeen RW: Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J Neurochem. 2001, 78: 736-745. 10.1046/j.1471-4159.2001.00456.x.CrossRefPubMed
42.
go back to reference Dousset V, Armand JP, Lacoste D, Mieze S, Letenneur L, Dartigues JF, Caill JM: Magnetization transfer study of HIV encephalitis and progressive multifocal leukoencephalopathy. Groupe d’Epidemiologie Clinique du SIDA en Aquitaine. AJNR Am J Neuroradiol. 1997, 18: 895-901.PubMed Dousset V, Armand JP, Lacoste D, Mieze S, Letenneur L, Dartigues JF, Caill JM: Magnetization transfer study of HIV encephalitis and progressive multifocal leukoencephalopathy. Groupe d’Epidemiologie Clinique du SIDA en Aquitaine. AJNR Am J Neuroradiol. 1997, 18: 895-901.PubMed
43.
go back to reference Ratai EM, Pilkenton SJ, Greco JB, Lentz MR, Bombardier JP, Turk KW, He J, Joo CG, Lee V, Westmoreland S, Halpern E, Lackner AA, González RG: In vivo proton magnetic resonance spectroscopy reveals region specific metabolic responses to SIV infection in the macaque brain. BMC Neurosci. 2009, 10: 63-10.1186/1471-2202-10-63.PubMedCentralCrossRefPubMed Ratai EM, Pilkenton SJ, Greco JB, Lentz MR, Bombardier JP, Turk KW, He J, Joo CG, Lee V, Westmoreland S, Halpern E, Lackner AA, González RG: In vivo proton magnetic resonance spectroscopy reveals region specific metabolic responses to SIV infection in the macaque brain. BMC Neurosci. 2009, 10: 63-10.1186/1471-2202-10-63.PubMedCentralCrossRefPubMed
44.
go back to reference Chang L, Ernst T, Witt MD, Ames N, Gaiefsky M, Miller E: Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naive HIV patients. Neuroimage. 2002, 17: 1638-1648. 10.1006/nimg.2002.1254.CrossRefPubMed Chang L, Ernst T, Witt MD, Ames N, Gaiefsky M, Miller E: Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naive HIV patients. Neuroimage. 2002, 17: 1638-1648. 10.1006/nimg.2002.1254.CrossRefPubMed
45.
go back to reference Tumati S, Martens S, Aleman A: Magnetic resonance spectroscopy in mild cognitive impairment: systematic review and meta-analysis. Neurosci Biobehav Rev. 2013, 37: 2571-2586. 10.1016/j.neubiorev.2013.08.004.CrossRefPubMed Tumati S, Martens S, Aleman A: Magnetic resonance spectroscopy in mild cognitive impairment: systematic review and meta-analysis. Neurosci Biobehav Rev. 2013, 37: 2571-2586. 10.1016/j.neubiorev.2013.08.004.CrossRefPubMed
46.
go back to reference Horder J, Lavender T, Mendez MA, O’Gorman R, Daly E, Craig MC, Lythgoe DJ, Barker GJ, Murphy DG: Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [(1)H]MRS study. Transl Psychiatry. 2013, 3: e279-10.1038/tp.2013.53.PubMedCentralCrossRefPubMed Horder J, Lavender T, Mendez MA, O’Gorman R, Daly E, Craig MC, Lythgoe DJ, Barker GJ, Murphy DG: Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [(1)H]MRS study. Transl Psychiatry. 2013, 3: e279-10.1038/tp.2013.53.PubMedCentralCrossRefPubMed
47.
go back to reference Barber TJ, Bradshaw D, Hughes D, Leonidou L, Margetts A, Ratcliffe D, Thornton S, Pozniak A, Asboe D, Mandalia S, Boffito M, Davies N, Gazzard B, Catalan J: Screening for HIV-related neurocognitive impairment in clinical practice: challenges and opportunities. AIDS Care. 2014, 26 (2): 160-168. 10.1080/09540121.2013.819401.CrossRefPubMed Barber TJ, Bradshaw D, Hughes D, Leonidou L, Margetts A, Ratcliffe D, Thornton S, Pozniak A, Asboe D, Mandalia S, Boffito M, Davies N, Gazzard B, Catalan J: Screening for HIV-related neurocognitive impairment in clinical practice: challenges and opportunities. AIDS Care. 2014, 26 (2): 160-168. 10.1080/09540121.2013.819401.CrossRefPubMed
48.
go back to reference Zipursky AR, Gogolishvili D, Rueda S, Brunetta J, Carvalhal A, McCombe JA, Gill MJ, Rachlis A, Rosenes R, Arbess G, Marcotte T, Rourke SB: Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature. Aids. 2013, 27 (15): 2385-2401. 10.1097/QAD.0b013e328363bf56.PubMedCentralCrossRefPubMed Zipursky AR, Gogolishvili D, Rueda S, Brunetta J, Carvalhal A, McCombe JA, Gill MJ, Rachlis A, Rosenes R, Arbess G, Marcotte T, Rourke SB: Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature. Aids. 2013, 27 (15): 2385-2401. 10.1097/QAD.0b013e328363bf56.PubMedCentralCrossRefPubMed
49.
go back to reference Zink WE, Anderson E, Boyle J, Hock L, Rodriguez-Sierra J, Xiong H, Gendelman HE, Persidsky Y: Impaired spatial cognition and synaptic potentiation in a murine model of human immunodeficiency virus type 1 encephalitis. J Neurosci. 2002, 22: 2096-2105.PubMed Zink WE, Anderson E, Boyle J, Hock L, Rodriguez-Sierra J, Xiong H, Gendelman HE, Persidsky Y: Impaired spatial cognition and synaptic potentiation in a murine model of human immunodeficiency virus type 1 encephalitis. J Neurosci. 2002, 22: 2096-2105.PubMed
50.
go back to reference Avgeropoulos N, Kelley B, Middaugh L, Arrigo S, Persidsky Y, Gendelman HE, Tyor WR: SCID mice with HIV encephalitis develop behavioral abnormalities. J Acquir Immune Defic Syndr Hum Retrovirol. 1998, 18: 13-20. 10.1097/00042560-199805010-00003.CrossRefPubMed Avgeropoulos N, Kelley B, Middaugh L, Arrigo S, Persidsky Y, Gendelman HE, Tyor WR: SCID mice with HIV encephalitis develop behavioral abnormalities. J Acquir Immune Defic Syndr Hum Retrovirol. 1998, 18: 13-20. 10.1097/00042560-199805010-00003.CrossRefPubMed
51.
go back to reference Hahn YK, Podhaizer EM, Farris SP, Miles MF, Hauser KF, Knapp PE: Effects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behavior. Brain Struct Funct. 2013, in press Hahn YK, Podhaizer EM, Farris SP, Miles MF, Hauser KF, Knapp PE: Effects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behavior. Brain Struct Funct. 2013, in press
52.
go back to reference D’Hooge R, Franck F, Mucke L, De Deyn PP: Age-related behavioural deficits in transgenic mice expressing the HIV-1 coat protein gp120. Eur J Neurosci. 1999, 11: 4398-4402. 10.1046/j.1460-9568.1999.00857.x.CrossRefPubMed D’Hooge R, Franck F, Mucke L, De Deyn PP: Age-related behavioural deficits in transgenic mice expressing the HIV-1 coat protein gp120. Eur J Neurosci. 1999, 11: 4398-4402. 10.1046/j.1460-9568.1999.00857.x.CrossRefPubMed
53.
go back to reference Paris JJ, Singh HD, Ganno ML, Jackson P, McLaughlin JP: Anxiety-like behavior of mice produced by conditional central expression of the HIV-1 regulatory protein, Tat. Psychopharmacology (Berl). 2014, 231: 2349-2360. 10.1007/s00213-013-3385-1.CrossRef Paris JJ, Singh HD, Ganno ML, Jackson P, McLaughlin JP: Anxiety-like behavior of mice produced by conditional central expression of the HIV-1 regulatory protein, Tat. Psychopharmacology (Berl). 2014, 231: 2349-2360. 10.1007/s00213-013-3385-1.CrossRef
54.
go back to reference Carey AN, Sypek EI, Singh HD, Kaufman MJ, McLaughlin JP: Expression of HIV-Tat protein is associated with learning and memory deficits in the mouse. Behav Brain Res. 2012, 229: 48-56. 10.1016/j.bbr.2011.12.019.PubMedCentralCrossRefPubMed Carey AN, Sypek EI, Singh HD, Kaufman MJ, McLaughlin JP: Expression of HIV-Tat protein is associated with learning and memory deficits in the mouse. Behav Brain Res. 2012, 229: 48-56. 10.1016/j.bbr.2011.12.019.PubMedCentralCrossRefPubMed
55.
go back to reference Avgeropoulos NG, Burris GW, Ohlandt GW, Wesselingh SL, Markham RB, Tyor WR: Potential relationships between the presence of HIV, macrophages, and astrogliosis in SCID mice with HIV encephalitis. J NeuroAIDS. 1998, 2: 1-20.PubMed Avgeropoulos NG, Burris GW, Ohlandt GW, Wesselingh SL, Markham RB, Tyor WR: Potential relationships between the presence of HIV, macrophages, and astrogliosis in SCID mice with HIV encephalitis. J NeuroAIDS. 1998, 2: 1-20.PubMed
56.
go back to reference Robertson K, Jiang H, Kumwenda J, Supparatpinyo K, Evans S, Campbell TB, Price R, Tripathy S, Kumarasamy N, La Rosa A, Santos B, Silva MT, Montano S, Kanyama C, Faesen S, Murphy R, Hall C, Marra CM, Marcus C, Berzins B, Allen R, Housseinipour M, Amod F, Sanne I, Hakim J, Walawander A, Nair A, 5199 Study Team: Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study. Clin Infect Dis. 2012, 55: 868-876. 10.1093/cid/cis507.PubMedCentralCrossRefPubMed Robertson K, Jiang H, Kumwenda J, Supparatpinyo K, Evans S, Campbell TB, Price R, Tripathy S, Kumarasamy N, La Rosa A, Santos B, Silva MT, Montano S, Kanyama C, Faesen S, Murphy R, Hall C, Marra CM, Marcus C, Berzins B, Allen R, Housseinipour M, Amod F, Sanne I, Hakim J, Walawander A, Nair A, 5199 Study Team: Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study. Clin Infect Dis. 2012, 55: 868-876. 10.1093/cid/cis507.PubMedCentralCrossRefPubMed
57.
go back to reference Al-Khindi T, Zakzanis KK, van Gorp WG: Does antiretroviral therapy improve HIV-associated cognitive impairment? A quantitative review of the literature. J Int Neuropsychol Soc. 2011, 17: 956-969. 10.1017/S1355617711000968.CrossRefPubMed Al-Khindi T, Zakzanis KK, van Gorp WG: Does antiretroviral therapy improve HIV-associated cognitive impairment? A quantitative review of the literature. J Int Neuropsychol Soc. 2011, 17: 956-969. 10.1017/S1355617711000968.CrossRefPubMed
58.
go back to reference Crusio WE: Genetic dissection of mouse exploratory behaviour. Behav Brain Res. 2001, 125: 127-132. 10.1016/S0166-4328(01)00280-7.CrossRefPubMed Crusio WE: Genetic dissection of mouse exploratory behaviour. Behav Brain Res. 2001, 125: 127-132. 10.1016/S0166-4328(01)00280-7.CrossRefPubMed
59.
go back to reference Jost CR, Van Der Zee CE, In ‘t Zandt HJ, Oerlemans F, Verheij M, Streijger F, Fransen J, Heerschap A, Cools AR, Wieringa B: Creatine kinase B-driven energy transfer in the brain is important for habituation and spatial learning behaviour, mossy fibre field size and determination of seizure susceptibility. Eur J Neurosci. 2002, 15: 1692-1706. 10.1046/j.1460-9568.2002.02001.x.CrossRefPubMed Jost CR, Van Der Zee CE, In ‘t Zandt HJ, Oerlemans F, Verheij M, Streijger F, Fransen J, Heerschap A, Cools AR, Wieringa B: Creatine kinase B-driven energy transfer in the brain is important for habituation and spatial learning behaviour, mossy fibre field size and determination of seizure susceptibility. Eur J Neurosci. 2002, 15: 1692-1706. 10.1046/j.1460-9568.2002.02001.x.CrossRefPubMed
60.
go back to reference Johnson RT, McArthur JC, Narayan O: The neurobiology of human immunodeficiency virus infections. FASEB J. 1988, 2: 2970-2981.PubMed Johnson RT, McArthur JC, Narayan O: The neurobiology of human immunodeficiency virus infections. FASEB J. 1988, 2: 2970-2981.PubMed
61.
go back to reference Ances BM, Ellis RJ: Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol. 2007, 27: 86-92. 10.1055/s-2006-956759.CrossRefPubMed Ances BM, Ellis RJ: Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol. 2007, 27: 86-92. 10.1055/s-2006-956759.CrossRefPubMed
62.
go back to reference Anderson E, Zink W, Xiong H, Gendelman HE: HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. J Acquir Immune Defic Syndr. 2002, 31 (Suppl 2): S43-S54.CrossRefPubMed Anderson E, Zink W, Xiong H, Gendelman HE: HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. J Acquir Immune Defic Syndr. 2002, 31 (Suppl 2): S43-S54.CrossRefPubMed
63.
go back to reference Valcour V, Sithinamsuwan P, Letendre S, Ances B: Pathogenesis of HIV in the central nervous system. Curr HIV/AIDS Rep. 2011, 8: 54-61. 10.1007/s11904-010-0070-4.PubMedCentralCrossRefPubMed Valcour V, Sithinamsuwan P, Letendre S, Ances B: Pathogenesis of HIV in the central nervous system. Curr HIV/AIDS Rep. 2011, 8: 54-61. 10.1007/s11904-010-0070-4.PubMedCentralCrossRefPubMed
64.
go back to reference Kraft-Terry SD, Buch SJ, Fox HS, Gendelman HE: A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection. Neuron. 2009, 64: 133-145. 10.1016/j.neuron.2009.09.042.PubMedCentralCrossRefPubMed Kraft-Terry SD, Buch SJ, Fox HS, Gendelman HE: A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection. Neuron. 2009, 64: 133-145. 10.1016/j.neuron.2009.09.042.PubMedCentralCrossRefPubMed
65.
go back to reference Spudich S, Gonzalez-Scarano F: HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment. Cold Spring Harb Perspect Med. 2012, 2: a007120-PubMedCentralCrossRefPubMed Spudich S, Gonzalez-Scarano F: HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment. Cold Spring Harb Perspect Med. 2012, 2: a007120-PubMedCentralCrossRefPubMed
66.
67.
go back to reference Gendelman HE, Orenstein JM, Martin MA, Ferrua C, Mitra R, Phipps T, Wahl LA, Lane HC, Fauci AS, Burke DS, Skillman D, Meltzer MS: Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med. 1988, 167: 1428-1441. 10.1084/jem.167.4.1428.CrossRefPubMed Gendelman HE, Orenstein JM, Martin MA, Ferrua C, Mitra R, Phipps T, Wahl LA, Lane HC, Fauci AS, Burke DS, Skillman D, Meltzer MS: Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med. 1988, 167: 1428-1441. 10.1084/jem.167.4.1428.CrossRefPubMed
68.
go back to reference Ratiney H, Coenradie Y, Cavassila S, van Ormondt D, Graveron-Demilly D: Time-domain quantitation of 1H short echo-time signals: background accommodation. MAGMA. 2004, 16: 284-296. 10.1007/s10334-004-0037-9.CrossRefPubMed Ratiney H, Coenradie Y, Cavassila S, van Ormondt D, Graveron-Demilly D: Time-domain quantitation of 1H short echo-time signals: background accommodation. MAGMA. 2004, 16: 284-296. 10.1007/s10334-004-0037-9.CrossRefPubMed
69.
go back to reference Ratiney H, Sdika M, Coenradie Y, Cavassila S, van Ormondt D, Graveron-Demilly D: Time-domain semi-parametric estimation based on a metabolite basis set. NMR Biomed. 2005, 18: 1-13. 10.1002/nbm.895.CrossRefPubMed Ratiney H, Sdika M, Coenradie Y, Cavassila S, van Ormondt D, Graveron-Demilly D: Time-domain semi-parametric estimation based on a metabolite basis set. NMR Biomed. 2005, 18: 1-13. 10.1002/nbm.895.CrossRefPubMed
70.
go back to reference Boska MD, Hasan KM, Kibuule D, Banerjee R, McIntyre E, Nelson JA, Hahn T, Gendelman HE, Mosley RL: Quantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson’s disease. Neurobiol Dis. 2007, 26: 590-596. 10.1016/j.nbd.2007.02.010.PubMedCentralCrossRefPubMed Boska MD, Hasan KM, Kibuule D, Banerjee R, McIntyre E, Nelson JA, Hahn T, Gendelman HE, Mosley RL: Quantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson’s disease. Neurobiol Dis. 2007, 26: 590-596. 10.1016/j.nbd.2007.02.010.PubMedCentralCrossRefPubMed
71.
go back to reference Basser PJ, Mattiello J, LeBihan D: Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson B. 1994, 103: 247-254. 10.1006/jmrb.1994.1037.CrossRefPubMed Basser PJ, Mattiello J, LeBihan D: Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson B. 1994, 103: 247-254. 10.1006/jmrb.1994.1037.CrossRefPubMed
72.
73.
go back to reference Hasan KM, Basser PJ, Parker DL, Alexander AL: Analytical computation of the eigenvalues and eigenvectors in DT-MRI. J Magn Reson. 2001, 152: 41-47. 10.1006/jmre.2001.2400.CrossRefPubMed Hasan KM, Basser PJ, Parker DL, Alexander AL: Analytical computation of the eigenvalues and eigenvectors in DT-MRI. J Magn Reson. 2001, 152: 41-47. 10.1006/jmre.2001.2400.CrossRefPubMed
74.
go back to reference Hasan KM: Diffusion tensor eigenvalues or both mean diffusivity and fractional anisotropy are required in quantitative clinical diffusion tensor MR reports: fractional anisotropy alone is not sufficient. Radiology. 2006, 239: 611-612. 10.1148/radiol.2392051172. author reply 612-613CrossRefPubMed Hasan KM: Diffusion tensor eigenvalues or both mean diffusivity and fractional anisotropy are required in quantitative clinical diffusion tensor MR reports: fractional anisotropy alone is not sufficient. Radiology. 2006, 239: 611-612. 10.1148/radiol.2392051172. author reply 612-613CrossRefPubMed
75.
go back to reference Westfall PH, Manage A: How well do multiple testing methods scale up when both n and k increase?. J Biopharm Stat. 2011, 21: 583-594. 10.1080/10543406.2011.551326.CrossRefPubMed Westfall PH, Manage A: How well do multiple testing methods scale up when both n and k increase?. J Biopharm Stat. 2011, 21: 583-594. 10.1080/10543406.2011.551326.CrossRefPubMed
Metadata
Title
Associations between brain microstructures, metabolites, and cognitive deficits during chronic HIV-1 infection of humanized mice
Authors
Michael D Boska
Prasanta K Dash
Jaclyn Knibbe
Adrian A Epstein
Sidra P Akhter
Natasha Fields
Robin High
Edward Makarov
Stephen Bonasera
Harris A Gelbard
Larisa Y Poluektova
Howard E Gendelman
Santhi Gorantla
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Molecular Neurodegeneration / Issue 1/2014
Electronic ISSN: 1750-1326
DOI
https://doi.org/10.1186/1750-1326-9-58

Other articles of this Issue 1/2014

Molecular Neurodegeneration 1/2014 Go to the issue